A Conversation With E.K. Koh, Chief Product Officer: How Suvoda Is Shaping The Future Of Clinical Trial Technology

By Elena Filimonova, Chief Marketing Officer

As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification. While many providers offer a collection of "bolted-together" point solutions—often sharing nothing more than a login screen and consistent branding—the real value for sponsors lies in a unified data layer. This foundational integration allows for "agentic" workflows where the system doesn't just display information but actively triggers the next logical step in a trial.

The transition from generative AI to agentic AI represents a significant leap for the industry. In a highly regulated environment, these tools must be more than just innovative; they must be auditable, traceable, and hyper-reliable. Imagine an ecosystem where a randomization event in an IRT system automatically triggers a travel booking prompt for the patient and a visit schedule for the site, all without manual intervention. By focusing on interoperability and user-friendly automation, the goal is to reduce the repetitive "hand-off" work that currently bogs down site staff.